Loading…
Reported covered position: Legislative Asst, Rep Jim Davis; Sr Legislative Asst, Rep Bart Stupak; Professional Staff, Energy & Commerce Committee; Sr Investigator, US Senate Committee on the Judiciary
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
H.R.1319- American Rescue Plan Act of 2021, prescription drug abuse and deterrence, non-interference, supply chain (no specific bills), drug pricing and innovation
H.R.1319- American Rescue Plan Act of 2021, prescription drug abuse and deterrence, non-interference, supply chain (no specific bills), drug pricing and innovation
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ASSOCIATION OF AIR MEDICAL SERVICES via ANWAY LONG GROUP
2021 · fourth_quarter · 4T
Issues related to surprise medical billing; S. 4185 End Surprise Medical Bills for Air Ambulances Act of 2020
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERISOURCEBERGEN CORPORATION via ANWAY LONG GROUP
2021 · fourth_quarter · 4T
Source: Senate LDA
| UNIVERSITY RADIOLOGY GROUP, P.C. |
| 4 |
| 2020 |
| PHLOW CORPORATION | 3 | 2020 |
H.R.1319- American Rescue Plan Act of 2021, drug pricing and innovation
H.R.1319- American Rescue Plan Act of 2021, prescription drug abuse and deterrence, non-interference, supply chain (no specific bills), drug pricing and innovation
H.R.1319- American Rescue Plan Act of 2021, drug pricing and innovation
H.R.1319- American Rescue Plan Act of 2021, drug pricing and innovation
H.R.1319- American Rescue Plan Act of 2021, prescription drug abuse and deterrence, non-interference, supply chain (no specific bills), drug pricing and innovation
H.R.1319- American Rescue Plan Act of 2021, drug pricing and innovation
End Surprise Medical Bills for Air Ambulances Act of 2020
Client: ASSOCIATION OF AIR MEDICAL SERVICES · Firm: ANWAY LONG GROUP
Issues related to surprise medical billing; S. 4185 End Surprise Medical Bills for Air Ambulances Act of 2020
End Surprise Medical Bills for Air Ambulances Act of 2020
Client: ASSOCIATION OF AIR MEDICAL SERVICES · Firm: ANWAY LONG GROUP
Issues related to surprise medical billing; S. 4185 End Surprise Medical Bills for Air Ambulances Act of 2020
End Surprise Medical Bills for Air Ambulances Act of 2020
Client: ASSOCIATION OF AIR MEDICAL SERVICES · Firm: ANWAY LONG GROUP
Issues related to surprise medical billing; S. 4185 End Surprise Medical Bills for Air Ambulances Act of 2020
End Surprise Medical Bills for Air Ambulances Act of 2020
Client: ASSOCIATION OF AIR MEDICAL SERVICES · Firm: ANWAY LONG GROUP
Issues related to surprise medical billing; S. 4185 End Surprise Medical Bills for Air Ambulances Act of 2020
End Surprise Medical Bills for Air Ambulances Act of 2020
Client: ASSOCIATION OF AIR MEDICAL SERVICES · Firm: ANWAY LONG GROUP
Issues related to surprise medical billing; S. 4185- End Surprise Medical Bills for Air Ambulances Act of 2020
S. 3787 - The DISARM Act of 2018; issues related to anti-microbial resistance
Issues related to drug supply chains; generic drug shortage.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FLORIDA MEDICAL ASSOCIATION via ANWAY LONG GROUP
2021 · fourth_quarter · 4T
Telehealth and sequestration; Out-of-Network Billing; COVID-19
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MALLINCKRODT LLC via ANWAY LONG GROUP
2021 · fourth_quarter · 4T
H.R.1319- American Rescue Plan Act of 2021, drug pricing and innovation
H.R.1319- American Rescue Plan Act of 2021, drug pricing and innovation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ANTIMICROBIALS WORKING GROUP via ANWAY LONG GROUP
2021 · fourth_quarter · 4T
DISARM Act; PASTEUR Act; reimbursement for antimicrobials; COVID-19
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF AIR MEDICAL SERVICES via ANWAY LONG GROUP
2021 · third_quarter · Q3
Issues related to surprise medical billing; S. 4185 End Surprise Medical Bills for Air Ambulances Act of 2020
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERISOURCEBERGEN CORPORATION via ANWAY LONG GROUP
2021 · third_quarter · Q3
Issues related to drug supply chains; generic drug shortage.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FLORIDA MEDICAL ASSOCIATION via ANWAY LONG GROUP
2021 · third_quarter · Q3
Telehealth and sequestration; Out-of-Network Billing; COVID-19
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MALLINCKRODT LLC via ANWAY LONG GROUP
2021 · third_quarter · Q3
H.R.1319- American Rescue Plan Act of 2021, drug pricing and innovation
H.R.1319- American Rescue Plan Act of 2021, drug pricing and innovation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ANTIMICROBIALS WORKING GROUP via ANWAY LONG GROUP
2021 · third_quarter · Q3
DISARM Act; PASTEUR Act; reimbursement for antimicrobials; COVID-19
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ANTIMICROBIALS WORKING GROUP via ANWAY LONG GROUP
2021 · second_quarter · Q2
DISARM Act; PASTEUR Act; reimbursement for antimicrobials; COVID-19
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF AIR MEDICAL SERVICES via ANWAY LONG GROUP
2021 · second_quarter · Q2
Issues related to surprise medical billing; S. 4185 End Surprise Medical Bills for Air Ambulances Act of 2020
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FLORIDA MEDICAL ASSOCIATION via ANWAY LONG GROUP
2021 · second_quarter · Q2
Telehealth and sequestration; Out-of-Network Billing; COVID-19
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MALLINCKRODT LLC via ANWAY LONG GROUP
2021 · second_quarter · Q2
H.R.1319- American Rescue Plan Act of 2021, prescription drug abuse and deterrence, non-interference, supply chain (no specific bills), drug pricing and innovation
H.R.1319- American Rescue Plan Act of 2021, prescription drug abuse and deterrence, non-interference, supply chain (no specific bills), drug pricing and innovation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERISOURCEBERGEN CORPORATION via ANWAY LONG GROUP
2021 · second_quarter · Q2
Issues related to drug supply chains; generic drug shortage.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF AIR MEDICAL SERVICES via ANWAY LONG GROUP
2021 · first_quarter · Q1
Issues related to surprise medical billing; S. 4185 End Surprise Medical Bills for Air Ambulances Act of 2020
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERISOURCEBERGEN CORPORATION via ANWAY LONG GROUP
2021 · first_quarter · Q1
Issues related to drug supply chains.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FLORIDA MEDICAL ASSOCIATION via ANWAY LONG GROUP
2021 · first_quarter · Q1
Telehealth and sequestration; Out-of-Network Billing; COVID-19
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MALLINCKRODT LLC via ANWAY LONG GROUP
2021 · first_quarter · Q1
H.R.1319- American Rescue Plan Act of 2021, prescription drug abuse and deterrence, non-interference, supply chain (no specific bills), drug pricing and innovation
H.R.1319- American Rescue Plan Act of 2021, prescription drug abuse and deterrence, non-interference, supply chain (no specific bills), drug pricing and innovation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ANTIMICROBIALS WORKING GROUP via ANWAY LONG GROUP
2021 · first_quarter · Q1
DISARM Act; PASTEUR Act; reimbursement for antimicrobials; COVID-19
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ANTIMICROBIALS WORKING GROUP via ANWAY LONG GROUP
2020 · fourth_quarter · 4A
DISARM Act; PASTEUR Act; reimbursement for antimicrobials; COVID-19
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF AIR MEDICAL SERVICES via ANWAY LONG GROUP
2020 · fourth_quarter · Q4
Issues related to surprise medical billing; S. 4185- End Surprise Medical Bills for Air Ambulances Act of 2020
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNIVERSITY RADIOLOGY GROUP, P.C. via ANWAY LONG GROUP
2020 · fourth_quarter · 4T
Issues related to COVID-19 Paycheck Protection Program; Provider Relief Fund
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERISOURCEBERGEN CORPORATION via ANWAY LONG GROUP
2020 · fourth_quarter · Q4
Issues related to drug supply chains.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE COMMUNITY HEALTH PLANS via ANWAY LONG GROUP
2020 · fourth_quarter · 4T
Issues related to Medicare Advantage
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FLORIDA MEDICAL ASSOCIATION via ANWAY LONG GROUP
2020 · fourth_quarter · Q4
Direct Primary Care; Out-of-Network Billing; COVID-19
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MALLINCKRODT LLC via ANWAY LONG GROUP
2020 · fourth_quarter · Q4
MAT legislation; opioids; drug pricing legislation; COVID-19
MAT legislation; opioids; drug pricing legislation; COVID-19
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ANTIMICROBIALS WORKING GROUP via ANWAY LONG GROUP
2020 · fourth_quarter · Q4
DISARM Act; PASTEUR Act; reimbursement for antimicrobials; COVID-19
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF AIR MEDICAL SERVICES via ANWAY LONG GROUP
2020 · fourth_quarter · RR
Issues related to surprise medical billing
ALLIANCE COMMUNITY HEALTH PLANS via ANWAY LONG GROUP
2020 · third_quarter · Q3
Issues related to Medicare Advantage
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNIVERSITY RADIOLOGY GROUP, P.C. via ANWAY LONG GROUP
2020 · third_quarter · Q3
Issues related to COVID-19 Paycheck Protection Program; Provider Relief Fund
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERISOURCEBERGEN CORPORATION via ANWAY LONG GROUP
2020 · third_quarter · Q3
Issues related to drug supply chains.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FLORIDA MEDICAL ASSOCIATION via ANWAY LONG GROUP
2020 · third_quarter · Q3
Direct Primary Care; Out-of-Network Billing; COVID-19
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MALLINCKRODT LLC via ANWAY LONG GROUP
2020 · third_quarter · Q3
MAT legislation; opioids; drug pricing legislation; COVID-19
MAT legislation; opioids; drug pricing legislation; COVID-19
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ANTIMICROBIALS WORKING GROUP via ANWAY LONG GROUP
2020 · third_quarter · Q3
DISARM Act; PASTEUR Act; reimbursement for antimicrobials; COVID-19
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHLOW CORPORATION via ANWAY LONG GROUP
2020 · second_quarter · 2T
Issues related to drug supply chains
Issues related to drug supply chains
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNIVERSITY RADIOLOGY GROUP, P.C. via ANWAY LONG GROUP
2020 · second_quarter · Q2
Issues related to COVID-19 Paycheck Protection Program; Provider Relief Fund
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERISOURCEBERGEN CORPORATION via ANWAY LONG GROUP
2020 · second_quarter · Q2
Issues related to drug supply chains.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHLOW CORPORATION via ANWAY LONG GROUP
2020 · second_quarter · Q2
Issues related to drug supply chains
Issues related to drug supply chains
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE COMMUNITY HEALTH PLANS via ANWAY LONG GROUP
2020 · second_quarter · 2T
Issues related to Medicare Advantage; COVID-19
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FLORIDA MEDICAL ASSOCIATION via ANWAY LONG GROUP
2020 · second_quarter · Q2
Direct Primary Care; Out-of-Network Billing; COVID-19
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MALLINCKRODT LLC via ANWAY LONG GROUP
2020 · second_quarter · Q2
MAT legislation; opioids; drug pricing legislation; COVID-19
MAT legislation; opioids; drug pricing legislation; COVID-19
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ANTIMICROBIALS WORKING GROUP via ANWAY LONG GROUP
2020 · second_quarter · Q2
DISARM Act; PASTEUR Act; reimbursement for antimicrobials; COVID-19
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNIVERSITY RADIOLOGY GROUP, P.C. via ANWAY LONG GROUP
2020 · second_quarter · RR
Issues related to COVID-19 Paycheck Protection Program
AMERISOURCEBERGEN CORPORATION via ANWAY LONG GROUP
2020 · second_quarter · RR
Issues related to supply chain
PHLOW CORPORATION via ANWAY LONG GROUP
2020 · second_quarter · RR
Issues related to Drug supply chain issues
Issues related to Drug supply chain issues
ANTIMICROBIALS WORKING GROUP via ANWAY LONG GROUP
2020 · first_quarter · Q1
DISARM Act; reimbursement for antimicrobials; COVID-19
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MALLINCKRODT LLC via ANWAY LONG GROUP
2020 · first_quarter · Q1
DEA Clearinghouse Act and other drug pricing legislation; COVID-19
DEA Clearinghouse Act and other drug pricing legislation; COVID-19
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FLORIDA MEDICAL ASSOCIATION via ANWAY LONG GROUP
2020 · first_quarter · Q1
GME Funding and Direct Primary Care; Out-of-Network Billing; COVID-19
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE COMMUNITY HEALTH PLANS via ANWAY LONG GROUP
2020 · first_quarter · Q1
Issues related to Medicare Advantage; COVID-19
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE COMMUNITY HEALTH PLANS via ANWAY LONG GROUP
2020 · first_quarter · RR
Medicare Advantage; COVID-19;
ANTIMICROBIALS WORKING GROUP via ANWAY LONG GROUP
2019 · fourth_quarter · 4A
DISARM Act; reimbursement for antimicrobials
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ANTIMICROBIALS WORKING GROUP via ANWAY LONG GROUP
2019 · third_quarter · 3A
DISARM Act; reimbursement for antimicrobials
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ANTIMICROBIALS WORKING GROUP via ANWAY LONG GROUP
2019 · second_quarter · 2A
DISARM Act; reimbursement for antimicrobials
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ANTIMICROBIALS WORKING GROUP via ANWAY LONG GROUP
2019 · first_quarter · 1A
DISARM Act; reimbursement for antimicrobials
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MALLINCKRODT LLC via ANWAY LONG GROUP
2019 · fourth_quarter · 4A
DEA Clearinghouse Act and other drug pricing legislation
DEA Clearinghouse Act and other drug pricing legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MALLINCKRODT LLC via ANWAY LONG GROUP
2019 · third_quarter · 3A
DEA Clearinghouse Act and other drug pricing legislation
DEA Clearinghouse Act and other drug pricing legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MALLINCKRODT LLC via ANWAY LONG GROUP
2019 · second_quarter · 2A
DEA Clearinghouse Act and other drug pricing legislation
DEA Clearinghouse Act and other drug pricing legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MALLINCKRODT LLC via ANWAY LONG GROUP
2019 · first_quarter · 1A
DEA Clearinghouse Act and other drug pricing legislation
DEA Clearinghouse Act and other drug pricing legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FLORIDA MEDICAL ASSOCIATION via ANWAY LONG GROUP
2019 · fourth_quarter · Q4
GME Funding and Direct Primary Care; Out-of-Network Billing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MALLINCKRODT LLC via ANWAY LONG GROUP
2019 · fourth_quarter · Q4
DEA Clearinghouse Act and other drug pricing legislation
DEA Clearinghouse Act and other drug pricing legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ANTIMICROBIALS WORKING GROUP via ANWAY LONG GROUP
2019 · fourth_quarter · Q4
DISARM Act; reimbursement for antimicrobials
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FLORIDA MEDICAL ASSOCIATION via ANWAY LONG GROUP
2019 · third_quarter · Q3
GME Funding and Direct Primary Care; Out-of-Network Billing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MALLINCKRODT LLC via ANWAY LONG GROUP
2019 · third_quarter · Q3
DEA Clearinghouse Act and other drug pricing legislation
DEA Clearinghouse Act and other drug pricing legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ANTIMICROBIALS WORKING GROUP via ANWAY LONG GROUP
2019 · third_quarter · Q3
DISARM Act; reimbursement for antimicrobials
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MALLINCKRODT LLC via ANWAY LONG GROUP
2019 · second_quarter · Q2
DEA Clearinghouse Act and other drug pricing legislation
DEA Clearinghouse Act and other drug pricing legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ANTIMICROBIALS WORKING GROUP via ANWAY LONG GROUP
2019 · second_quarter · Q2
DISARM Act; reimbursement for antimicrobials
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FLORIDA MEDICAL ASSOCIATION via ANWAY LONG GROUP
2019 · second_quarter · Q2
GME Funding and Direct Primary Care; Out-of-Network Billing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FLORIDA MEDICAL ASSOCIATION via ANWAY LONG GROUP
2019 · first_quarter · Q1
GME Funding and Direct Primary Care
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MALLINCKRODT LLC via ANWAY LONG GROUP
2019 · first_quarter · Q1
DEA Clearinghouse Act and other drug pricing legislation
DEA Clearinghouse Act and other drug pricing legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ANTIMICROBIALS WORKING GROUP via ANWAY LONG GROUP
2019 · first_quarter · Q1
DISARM Act; reimbursement for antimicrobials
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FLORIDA MEDICAL ASSOCIATION via ANWAY LONG GROUP
2019 · first_quarter · RR
GME funding and Direct Primary Care
ANTIMICROBIALS WORKING GROUP via ANWAY LONG GROUP
2018 · fourth_quarter · 4A
S. 3787 - The DISARM Act of 2018; issues related to anti-microbial resistance
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MALLINCKRODT LLC via ANWAY LONG GROUP
2018 · fourth_quarter · Q4
Issues related to Medicare Part D
Issues related to opioid abuse and alternatives to opioids.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ANTIMICROBIALS WORKING GROUP via ANWAY LONG GROUP
2018 · fourth_quarter · RR
Issues related to antimicrobial resistance; issues related to the development of innovative infectious disease treatments.
Issues related to antimicrobial resistance; issues related to the development of innovative infectious disease treatments.
MALLINCKRODT LLC via ANWAY LONG GROUP
2018 · fourth_quarter · RR
Issues related to opioid abuse and alternatives to opioids, issues related to Medicare Part D.
Issues related to opioid abuse and alternatives to opioids, issues related to Medicare Part D.
Issues related to opioid abuse and alternatives to opioids, issues related to Medicare Part D.